Antibiotic resistance profiles of Acinetobacter sp. strains isolated from intensive-care unit patients. 2012

Elvira Borcan, and Camelia Ghiţă, and Mariana Carmen Chifiriuc, and Veronica Lazăr
Bacteriology Laboratory of Fundeni Clinical Institute, Sos. Fundeni 258, Bucharest, Romania.

Multidrug resistance and the increasing number of severe infections caused by Acinetobacter sp. strains are a major issue for intensive care units (ICUs), where patients with severe diseases and often destabilized physiological condition are admitted. The aim of this study was to investigate the antibiotic resistance profiles of 200 Acinetobacter spp. isolated from tracheal aspirates in patients admitted to ICU, Fundeni Clinical Institute (FCI). METHODS the samples were collected from intubated patients between January 2006-December 2007. The microbial strains were identified with the help of the BD Phoenix system. The investigation of the antibiotic resistance patterns was performed by agar disk diffusion method according to CLSI recommendations, and the production of metallo-betalactamases (MBL) was confirmed by MBL E-test. RESULTS the majority of the studied strains (80%) were multidrug resistant with a high percentage of panresistance (32%). Metallo-beta-lactamases production among the strains with resistance to imipenem was high (over 83%), these strains being also resistant to the majority of the other tested antibiotics with the exception of colistin. CONCLUSIONS Our results confirmed that the multidrug resistance is the major threat of Acinetobacter sp. infections, especially when they occur in high risk patients.

UI MeSH Term Description Entries
D007362 Intensive Care Units Hospital units providing continuous surveillance and care to acutely ill patients. ICU Intensive Care Units,Intensive Care Unit,Unit, Intensive Care
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000150 Acinetobacter A genus of gram-negative bacteria of the family MORAXELLACEAE, found in soil and water and of uncertain pathogenicity. Herellea,Mima
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D024881 Drug Resistance, Bacterial The ability of bacteria to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance, Bacterial,Antibacterial Drug Resistance

Related Publications

Elvira Borcan, and Camelia Ghiţă, and Mariana Carmen Chifiriuc, and Veronica Lazăr
January 1995, Acta microbiologica et immunologica Hungarica,
Elvira Borcan, and Camelia Ghiţă, and Mariana Carmen Chifiriuc, and Veronica Lazăr
January 2014, Turkish journal of medical sciences,
Elvira Borcan, and Camelia Ghiţă, and Mariana Carmen Chifiriuc, and Veronica Lazăr
January 2016, Anaesthesiology intensive therapy,
Elvira Borcan, and Camelia Ghiţă, and Mariana Carmen Chifiriuc, and Veronica Lazăr
January 2017, BioMed research international,
Elvira Borcan, and Camelia Ghiţă, and Mariana Carmen Chifiriuc, and Veronica Lazăr
February 2011, Klinicheskaia laboratornaia diagnostika,
Elvira Borcan, and Camelia Ghiţă, and Mariana Carmen Chifiriuc, and Veronica Lazăr
January 1995, Annales de biologie clinique,
Elvira Borcan, and Camelia Ghiţă, and Mariana Carmen Chifiriuc, and Veronica Lazăr
March 2012, Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics,
Elvira Borcan, and Camelia Ghiţă, and Mariana Carmen Chifiriuc, and Veronica Lazăr
August 2023, The Malaysian journal of medical sciences : MJMS,
Elvira Borcan, and Camelia Ghiţă, and Mariana Carmen Chifiriuc, and Veronica Lazăr
June 2002, Journal of chemotherapy (Florence, Italy),
Elvira Borcan, and Camelia Ghiţă, and Mariana Carmen Chifiriuc, and Veronica Lazăr
January 2017, PloS one,
Copied contents to your clipboard!